Grounds insufficient to offer aducanumab for moderate, advanced Alzheimer dementia or patients without biomarker evidence of brain ß-amyloid
In patients undergoing knee arthroplasty, postoperative incidence of venous thromboembolism lower with milvexian versus enoxaparin
Phase 1 trial will include 16 patients ages 60 to 85 years who have early, symptomatic Alzheimer disease but are otherwise in good health
Additional symptoms can be used to update QCancer, a risk prediction model that helps physicians identify patients at high risk for cancer
Remote monitoring service, COVID Watch, reduced deaths at 30 and 60 days and was associated with presentation to emergency department sooner
EaseVRx system uses number of cognitive behavioral therapy methods to achieve pain relief
After adjustment for prevalent and interim stroke, risk for developing epilepsy increased almost twofold
Disparities in subsequent MRIs more pronounced at higher PSA thresholds
Among COVID-19-positive adults, outcomes better for those with prior bariatric surgery versus those eligible for bariatric surgery
Higher fish intake linked to lower cerebrovascular disease burden based on brain MRI markers, especially among participants younger than 75 years
Please login or register first to view this content.
Login Register